Biopharmaceutical manufacturing has a natural risk of contamination. What can you do about it?
The problem with traditional mAb manufacturing is that there are so many potential entry points for microbial contamination. This makes bioburden prevention and control in the production facility extremely important. It also underlines the risk that human error will be the cause of a contamination incident.
View this infographic visualizing all the potential entry points or read the article “Bioburden sources you might have missed."